The FDA has approved Boston Scientifics new device for stroke patients with irregular heart rhythm known as atrial fibrillation, and will be made available to U.S. centers involved in Boston Scientific’s clinical studies and additional specialized centers, according to Reuters.com.  For more information on this device approval, please visit:  http://www.reuters.com/article/2015/03/13/us-boston-scient-fda-idUSKBN0M92NX20150313